Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bioceres Crop Solutions (BIOX) Interest & Investment Income (2017 - 2019)

Historic Interest & Investment Income for Bioceres Crop Solutions (BIOX) over the last 3 years, with Q4 2019 value amounting to $2.2 million.

  • Bioceres Crop Solutions' Interest & Investment Income rose 95583.66% to $2.2 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$20.5 million, marking a year-over-year decrease of 51600.55%. This contributed to the annual value of $633741.0 for FY2023, which is 9097.2% down from last year.
  • Bioceres Crop Solutions' Interest & Investment Income amounted to $2.2 million in Q4 2019, which was up 95583.66% from $611709.0 recorded in Q3 2019.
  • Bioceres Crop Solutions' Interest & Investment Income's 5-year high stood at $20.1 million during Q1 2019, with a 5-year trough of -$43.4 million in Q2 2019.
  • Moreover, its 3-year median value for Interest & Investment Income was $409763.0 (2018), whereas its average is -$2.3 million.
  • Examining YoY changes over the last 5 years, Bioceres Crop Solutions' Interest & Investment Income showed a top increase of 95583.66% in 2019 and a maximum decrease of 31278.38% in 2019.
  • Quarter analysis of 3 years shows Bioceres Crop Solutions' Interest & Investment Income stood at $4.0 million in 2017, then plummeted by 94.86% to $207817.0 in 2018, then soared by 955.84% to $2.2 million in 2019.
  • Its Interest & Investment Income was $2.2 million in Q4 2019, compared to $611709.0 in Q3 2019 and -$43.4 million in Q2 2019.